Trial Profile
A study to evaluate the effect of Sugammadex on postoperative bleeding in patients who underwent cardiac surgery with cardiopulmonary bypass
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Sugammadex (Primary)
- Indications Neuromuscular blockade
- Focus Therapeutic Use
- 02 Mar 2016 New trial record